Trending...
- Tacoma: Statement from District 4 Council Member Sandesh Sadalge on the Critical Importance of Centering Equity in Regional Transit Decisions
- Michele Mundy's "Divinely Tailored" Gains Momentum
- Colorfront Launches New Mac App For Creating Apple Immersive Video
~ In a groundbreaking move, the Tacoma City Council has passed Resolution 41609, declaring entheogen-related activities as the lowest law enforcement priority within the city. The resolution, which was brought forward by District 5 Council Member Joe Bushnell and co-sponsored by Mayor Victoria Woodards, At-large Council Member Olgy Diaz, and District 3 Council Member Jamika Scott, aims to open doors for mental health treatment research by decriminalizing entheogens.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
- Spokane: Proposal Seeks to Advance Affordable Housing Projects Through Targeted TIF Investment
- Freedomtech Solutions creates 'Global Data Centre Network (IDCN)'
- Dual-Engine Growth Strategy Ignited: AI Infrastructure Breakout Meets Scalable Circular Economy Expansion: Marwynn Holdings, Inc. (N A S D A Q: MWYN)
- Super Bowl Champion Marvel Smith Inspires Launch of MVP-IQ Platform to Help Football Players Develop and Get Recruited Like the Pros
- The Future of Classic Cars in a World Moving Beyond Gasoline: How Electric Conversion Is Saving America's Automotive Heritage
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
0 Comments
Latest on Washingtoner
- Igniting High-Growth Expansion as Electrification Strategy and Infrastructure Dominance Converge; 88% Revenue Growth (N Y S E: MWG)
- Appliance EMT Presents Multi-Thousand Dollar Donation to Kids Motel Ministry to Support Local Families
- New Report Reveals Plane Crashes Are Not Where You'd Think
- City Council Adopts Updated Resolution for 'Connect Tacoma' Ballot Proposition
- Vangal Invests $3M Seed in Help Viber, Expanding into AI-Powered Customer Support and Communication
- Whiteside & Goldberg Investigating Claims on Behalf of Victims in TJ Maxx Hidden Camera Incident in Machesney Park, Illinois
- "Fearless and Free": Long Beach Pride 2026 Celebrates Resilience, Family, and Multicultural Connection
- 50 Years of Small Business Wisdom, Supercharged by AI: Shelly Berman Launches The Business Health Check
- Deborah E. Jones Releases Emotional Sovereignty, a Book on Emotional Awareness and Self-Regulation
- Finding the Best Lawyer: What Really Matters When Your Case Is on the Line
- The New World of Freight Brokering with AI
- Captain Notepad Launches Full-Service Direct Mail Platform for Small Businesses Nationwide
- World Cup Buzz Fuels Nayarit's Rise as Mexico's Pacific Standout
- Nayarit strengthens its position in Mexico's Culinary Elite with 8 restaurants in the 2026 Mexico Gastronomic Guide
- Winter Garden Ski Lake Home Sells for $2.05M in Cash Transaction, Highlighting Demand for Strategically Positioned Luxury Properties
- Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania
- As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
- FOCUS Hires Carrier-Side Operations Leader to Build the Next Generation of Insurance Service Delivery
- Adams Security Group LLC Launches New Website to Expand Professional Security Services Across Florida
- Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge